By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
AdkhabarAdkhabarAdkhabar
Notification Show More
Font ResizerAa
  • Automobile
  • Esports
  • Food
  • Life Style
  • Technology
    TechnologyShow More
    Water Ways Seeks Shareholder Approval for Potential Share Consolidation
    Water Ways Seeks Shareholder Approval for Potential Share Consolidation
    19/06/2025
    Artificial Intelligence Risk, Inc. and Fynancial, Inc. Awarded Best in Show at RIA Edge for Fyn, the First Agentic AI Powered Assistant for Financial Advisors
    Artificial Intelligence Risk, Inc. and Fynancial, Inc. Awarded Best in Show at RIA Edge for Fyn, the First Agentic AI Powered Assistant for Financial Advisors
    19/06/2025
    Red Cat Holdings Announces Closing of .75 Million Registered Direct Offering of Common Stock
    Red Cat Holdings Announces Closing of $46.75 Million Registered Direct Offering of Common Stock
    19/06/2025
    OTOFIX Introduces the D1 Lite Diagnostic Tool, Purpose-Built for Small Garage Technicians
    OTOFIX Introduces the D1 Lite Diagnostic Tool, Purpose-Built for Small Garage Technicians
    17/06/2025
    Power Queen’s Father’s Day Hot Battery Offer Opens for a Limited Time
    Power Queen’s Father’s Day Hot Battery Offer Opens for a Limited Time
    17/06/2025
  • Posts
    • Gallery Layouts
    • Video Layouts
    • Audio Layouts
    • Content Features
    • Table of Contents
  • Travel
  • Post Layouts
  • Post Sidebar
  • Review
    • User Rating
  • Pages
    • Search Page
    • 404 Page
Reading: Teddy Laboratory (GuanHe Pharmaceuticals) Signs Strategic Cooperation Agreement with LabConnect to Forge a New Landscape in Laboratory Services Collaboration
Share
Font ResizerAa
AdkhabarAdkhabar
  • Entertainment
  • Technology
Search
  • Home
  • Automobile
  • Esports
  • Food
  • Life Style
  • Categories
    • Technology
    • Entertainment
    • Health
  • Travel
  • Bookmarks
  • More Foxiz
    • Sitemap
Follow US
Adkhabar > Blog > News > Teddy Laboratory (GuanHe Pharmaceuticals) Signs Strategic Cooperation Agreement with LabConnect to Forge a New Landscape in Laboratory Services Collaboration
Teddy Laboratory (GuanHe Pharmaceuticals) Signs Strategic Cooperation Agreement with LabConnect to Forge a New Landscape in Laboratory Services Collaboration
News

Teddy Laboratory (GuanHe Pharmaceuticals) Signs Strategic Cooperation Agreement with LabConnect to Forge a New Landscape in Laboratory Services Collaboration

Last updated: 07/06/2025 1:08 PM
Published: 04/06/2025
Share
SHARE

JOHNSON CITY, Tenn., May 30, 2025 /PRNewswire/ — Teddy Laboratory, a subsidiary of Tigermed, officially signed a strategic cooperation agreement with LabConnect, LLC, a global leader in central laboratory services. The two parties will jointly build a full-chain laboratory service system covering both China and international markets to accelerate the development and commercialization of innovative drugs worldwide.

- Advertisement -

With this agreement, Teddy Laboratory will become LabConnect’s preferred laboratory partner in China, providing lab services that meet international regulatory standards and supporting multinational pharmaceutical companies conducting clinical trials in China. Meanwhile, LabConnect will become Teddy Lab’s preferred central lab partner for overseas operations, leveraging its extensive presence in key markets such as North America and Europe to help Chinese pharmaceutical companies expand globally.

- Advertisement -

Teddy Laboratory and LabConnect will establish a long-term preferred partnership, forming a complementary model of “China-based capabilities + global service network.”  “By fully leveraging our respective resources and technological strengths, we aim to further enhance global clinical trial service standards,” said Jeff Mayhew Chief Development Officer of LabConnect.

- Advertisement -

At the signing ceremony, Ms. Xu Yi, Chairwoman of Teddy Laboratory/GuanHe Pharmaceuticals, stated “LabConnect’s unique business model aligns well with Teddy’s localized strengths. Since our first Phase III clinical project together in 2022, we have successfully completed multiple international clinical trial collaborations.”

- Advertisement -

This strategic partnership marks not only a key milestone in Teddy Laboratories global expansion but also a deep integration of domestic and international central lab resources. In the future, both parties will continue working together to enhance global clinical trial service capabilities, support the development and launch of innovative drugs worldwide, and bring more advanced treatment options to patients.

- Advertisement -

About LabConnect

- Advertisement -

LabConnect is the leading provider of Central Laboratory Services, FSP and Scientific Consulting, and Data Integration and Transformation Services for analytically and logistically complex studies such as immuno-oncology, cell and gene therapies, and rare & orphan diseases. LabConnect’s unique combination of state-of-the-art technology, world-class laboratories, easy access to major and emerging markets, and extensive specialized testing expertise means that drug development companies can rely on one provider for all their central laboratory service needs. Learn more at www.labconnect.com and follow on LinkedIn.

- Advertisement -

About Teddy Laboratory/GuanHe Pharmaceuticals

- Advertisement -

Shanghai GuanHe Pharmaceutical Technology Co., Ltd., established in 2016, is a leading innovative and integrated lab service platform in the clinical research industry. With branches in Shanghai, Wuxi, Hangzhou, and Hong Kong, the company has built a one-stop service capability in central laboratory and bioanalysis, becoming an important player in full-chain clinical trial services. Teddy is a subsidiary controlled by Tigermed (300347.SZ / 3347.HK).

- Advertisement -

Teddy provides laboratory and scientific solutions to innovative drug companies to accelerate drug development and regulatory submissions. Its services span from biomarker discovery, target validation, patient enrichment, PK/PD studies, safety evaluation, to efficacy assessment and sample analysis. Teddy is committed to supporting clinical drug development with cutting-edge lab technologies. As of March 2025, Teddy has supported the approval of 37 new drugs and therapeutic products by China’s NMPA.

- Advertisement -

Logo – https://mma.prnewswire.com/media/2611513/LabConnect_Logo.jpg

- Advertisement -
NuggMD Now Serves All Eligible Medical Cannabis Patients Nationwide via Secure Telehealth Platform
Vish Iyer Joins Caelux as Managing Director, India and Middle East, to Spearhead Strategic Growth and Market Expansion in Two of the World’s Fastest-Growing Solar Markets
Altair to Showcase AI-Powered Engineering, Smart Manufacturing, and Connected Aerospace Solutions at Paris Air Show 2025
The Future of Luxury Is Personal: How ‘About the Space’ Designs for Form, Function and ‘Feelings’
MEXC Hits 40M Users with 46% Growth in New Listing Token Trading Volume in May
TAGGED:(guanheagreementbecomecentralchinacityclinicalcollaborationcompaniescooperation?developmentforgeglobalinternationaljohnsonlablabconnectlaboratoryLandscapeleveragingmarketsmaynewnewsofficiallypartnerpharmaceuticalpharmaceuticalspreferredserviceservicessignedsignsstandardsstrategicsubsidiaryteddytenntigermeduncategorizedwillwith
Share This Article
Facebook Email Print
- Advertisement -

Follow US

Find US on Social Medias
FacebookLike
XFollow
YoutubeSubscribe

Weekly Newsletter

Subscribe to our newsletter to get our newest articles instantly!
Popular News
Bybit Private Wealth Management’s Top Performing Fund Delivered 12.66% APR in May
News

Bybit Private Wealth Management’s Top Performing Fund Delivered 12.66% APR in May

10/06/2025
Kia launches premium streaming service across Europe
Global Panel Urges Rapid Reform of WHO and FCTC to Embrace Science, Transparency, and Consumer Voices
Ambiq Receives Frost & Sullivan’s 2025 Global Company of the Year Award for Its Leadership in Healthcare Semiconductor Solutions
Annexon Bolsters Ophthalmology Expertise with Appointment of Retina Specialist Lloyd Clark, M.D., as Pivotal ANX007 Program Advances in Dry Age-Related Macular Degeneration (AMD) with Geographic Atrophy (GA)
- Advertisement -
- Advertisement -

Categories

  • Automobile
  • Entertainment
  • E-Sports
  • Food
  • Health
  • Technology
  • LifeStyle
  • Travel

About Us

Through our news networks, we raise millions of users' awareness. We are among the world's most reputable news networks.
Quick Link
Top Categories
  • Entertainment

Subscribe US

Subscribe to our newsletter to get our newest articles instantly!

AdkhabarAdkhabar
Copyright © 2021 - 2025 AdKhabar. All Rights Reserved. POWERED BY Life Care News.
Join Us!
Subscribe to our newsletter and never miss our latest news, podcasts etc..
Zero spam, Unsubscribe at any time.
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?